Valemetostat

Scientific Overview: Dual EZH1/2 inhibitor; Japan approved for R/R ATLL 2021 and PTCL 2023. Dual EZH1/2 inhibition — prevents EZH1 compensation

Mechanism of Action: EZH1/2 Dual Inhibitor

Purity: ≥99%  |  Molecular Formula: C28H37FN6O2S

For Research Use Only. Not intended for diagnostic, therapeutic, or clinical applications.